Dosing systems and approaches
Inventors
Wu, Chia-Jung • Clark, Nicholas J. • Maheshwari, Ronak • Franey, Heather N.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-12329720-B2
Publication Date
2025-06-17
Expiration Date
Abstract
A drug delivery system includes a delivery container, a first drug insertion port, at least one additional drug insertion port, and an IV connection port. The delivery container includes upper, lower, first side, and second side portions, and further includes a tapered region extending between the first side portion and the second side portion. The first drug insertion port is positioned at the lower portion of the delivery container and has a first coupling mechanism. The at least one additional drug insertion port is also positioned at the lower portion of the delivery container, but includes a second coupling mechanism that is different than the first coupling mechanism. The IV connection port is positioned at the lower portion of the delivery container adjacent to a lower portion of the tapered region.
Core Innovation
A drug delivery system includes a delivery container having an upper portion, a lower portion, a first side portion, a second side portion, and a tapered region extending between the first side portion and the second side portion. The delivery container includes an interior cavity, and the tapered region includes a surface area between seams defining the interior cavity. The surface area is downwardly angled from the first side portion toward an IV connection port.
The delivery container includes a first drug insertion port positioned at the lower portion through the surface area of the tapered region, where the first drug insertion port has a luer lock. The delivery container also includes at least one additional drug insertion port positioned at the lower portion through the surface area of the tapered region, where the at least one additional drug insertion port does not have a luer lock. The delivery container further includes an IV connection port positioned at the lower portion adjacent to a lower portion of the tapered region.
In one configuration, the system further includes a rigid container defining an inner volume, with an upper portion and a lower portion. The rigid container includes mounting posts dimensioned to receive openings of the delivery container to operably secure the delivery container within the inner volume of the rigid container. The lower portion of the rigid container includes an opening to accommodate at least one of the IV connection port or an IV line, and the delivery container may include at least one opening formed in the upper portion.
Claims Coverage
The document provides two independent claims. Both independent claims include four core inventive elements: a delivery container with a downwardly angled tapered region forming a surface area of an interior cavity, a luer-locked first drug insertion port, at least one additional lower drug insertion port without a luer lock, and an IV connection port adjacent to the tapered region; the second independent claim additionally recites a rigid container with mounting posts and a lower opening for an IV connection or IV line.
Downwardly angled tapered-region surface area for interior cavity
A delivery container including an upper portion, a lower portion, a first side portion, a second side portion, and a tapered region extending between the first side portion and the second side portion, where the delivery container includes an interior cavity and the tapered region includes a surface area between seams defining the interior cavity, and wherein the surface area is downwardly angled from the first side portion toward the IV connection port.
Luer-locked first drug insertion port through tapered-region surface area
A first drug insertion port positioned at the lower portion of the delivery container through the surface area of the tapered region, where the first drug insertion port has a luer lock.
Additional lower drug insertion port without luer lock
At least one additional drug insertion port positioned at the lower portion of the delivery container through the surface area of the tapered region, where the at least one additional drug insertion port does not have a luer lock.
IV connection port adjacent tapered region with downward angle relationship
An IV connection port positioned at the lower portion of the delivery container adjacent to a lower portion of the tapered region, where the surface area is downwardly angled from the first side portion toward the IV connection port.
Rigid container with mounting posts and IV opening
A rigid container defining an inner volume with an upper portion and a lower portion, where the upper portion includes at least one mounting post dimensioned to receive at least one opening of the delivery container to operably secure the delivery container within the inner volume, and where the lower portion includes an opening to accommodate at least one of the IV connection port or an IV line.
Across the independent claims, the inventive structure is anchored by the downwardly angled tapered region that provides a surface area for positioning multiple lower drug insertion ports, combined with a luer-locked first port and at least one additional non-luer-lock port, plus an IV connection port adjacent the tapered region. The second independent claim further integrates this delivery container into a rigid outer container using mounting posts and an opening for the IV connection or IV line.
Stated Advantages
Reduced drug hold-up.
Faster container swaps.
Minimizing the need to stock multiple CSTD devices.
Documented Applications
An IV drug delivery system configured with a delivery container and an IV connection port for compatibility with closed system transfer device (CSTD) port types.
Interested in licensing this patent?